Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults ≥ 50 Years of Age
Chlibek, Roman, Bayas, José M., Collins, Harry, de la Pinta, Maria Luisa Rodriguez, Ledent, Edouard, Mols, Johann F., Heineman, Thomas C.
Published in The Journal of infectious diseases (15.12.2013)
Published in The Journal of infectious diseases (15.12.2013)
Get full text
Journal Article
Joint detection of important biomarkers and optimal dose-response model using penalties
Vandenhende, F., Eilers, P., Ledent, E., Renard, D., Tibaldi, F.
Published in Statistics in medicine (30.11.2007)
Published in Statistics in medicine (30.11.2007)
Get full text
Journal Article
Improved CD4 super(+) T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: A randomized trial
Leroux-Roels, I, gus, S, De Boever, F, Clement, F, Demoitie, M-A, Mettens, P, Moris, P, Ledent, E, Leroux-Roels, G, Ofori-Anyinam, O
Published in Vaccine (19.04.2013)
Get full text
Published in Vaccine (19.04.2013)
Journal Article